These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32588527)

  • 1. Cariprazine treatment of borderline personality disorder: A case report.
    Grant JE; Chamberlain SR
    Psychiatry Clin Neurosci; 2020 Sep; 74(9):511-512. PubMed ID: 32588527
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of add-on treatment with quetiapine on measures of depression, aggression, irritability and suicidal tendencies in children and adolescents.
    Podobnik J; Foller Podobnik I; Grgic N; Marcinko D; Pivac N
    Psychopharmacology (Berl); 2012 Apr; 220(3):639-41. PubMed ID: 22173852
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhaled Loxapine for Acute Treatment of Agitation in Patients With Borderline Personality Disorder: A Case Series.
    Kahl KG; Negt P; Wollmer A; Jung S; Kruger TH
    J Clin Psychopharmacol; 2015 Dec; 35(6):741-3. PubMed ID: 26448403
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-Acting Aripiprazole in Comorbid Bipolar Disorder and Borderline Personality Disorder and Substance Abuse.
    Martínez JS; Caballero AR
    J Clin Psychopharmacol; 2017 Apr; 37(2):266-267. PubMed ID: 28145998
    [No Abstract]   [Full Text] [Related]  

  • 5. Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pascual JC; Madre M; Soler J; Barrachina J; Campins MJ; Alvarez E; Pérez V
    Pharmacopsychiatry; 2006 May; 39(3):117-8. PubMed ID: 16721704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of borderline personality disorder with olanzapine.
    Shoja-Shafti S
    Arch Iran Med; 2006 Oct; 9(4):403-5. PubMed ID: 17061615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is psychopharmacological treatment effective for the symptoms of borderline personality disorder (BPD)?
    Paris J
    J Psychiatry Neurosci; 1999 May; 24(3):262. PubMed ID: 10354663
    [No Abstract]   [Full Text] [Related]  

  • 8. New developments in the neurobiology of borderline personality disorder.
    Bohus M; Schmahl C; Lieb K
    Curr Psychiatry Rep; 2004 Feb; 6(1):43-50. PubMed ID: 14738705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine in borderline personality disorder: a review of the evidence.
    Beri A; Boydell J
    Ann Clin Psychiatry; 2014 May; 26(2):139-44. PubMed ID: 24812651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asenapine in the management of impulsivity and aggressiveness in bipolar disorder and comorbid borderline personality disorder: an open-label uncontrolled study.
    Aguglia A; Mineo L; Rodolico A; Signorelli MS; Aguglia E
    Int Clin Psychopharmacol; 2018 May; 33(3):121-130. PubMed ID: 29189421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cariprazine Augmentation to Antidepressant Therapy in Major Depressive Disorder: Results of a Randomized, Double-Blind, Placebo-Controlled Trial.
    Earley WR; Guo H; Németh G; Harsányi J; Thase ME
    Psychopharmacol Bull; 2018 Jun; 48(4):62-80. PubMed ID: 30618475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic treatments for borderline personality disorder.
    Tohen M
    Am J Psychiatry; 2014 Nov; 171(11):1139-41. PubMed ID: 25756626
    [No Abstract]   [Full Text] [Related]  

  • 13. Clozapine for the Management of Suicidal Behavior in Borderline Personality Disorder Complicated by a Cancer Diagnosis: A Case Report and Review of the Literature.
    OʼLeary J; Purcell A; Hynes C; Huet J; Romanos M; McWilliams S
    J Clin Psychopharmacol; 2018 Dec; 38(6):642-644. PubMed ID: 30334867
    [No Abstract]   [Full Text] [Related]  

  • 14. Aripiprazole treatment of patients with borderline personality disorder.
    Nickel MK
    J Clin Psychiatry; 2007 Nov; 68(11):1815-6. PubMed ID: 18052583
    [No Abstract]   [Full Text] [Related]  

  • 15. Ziprasidone in the acute treatment of borderline personality disorder in psychiatric emergency services.
    Pascual JC; Oller S; Soler J; Barrachina J; Alvarez E; Pérez V
    J Clin Psychiatry; 2004 Sep; 65(9):1281-2. PubMed ID: 15367057
    [No Abstract]   [Full Text] [Related]  

  • 16. Aripiprazole in a therapy-resistant patient with borderline personality and post-traumatic stress disorder.
    Kellner M
    Pharmacopsychiatry; 2007 Jan; 40(1):41. PubMed ID: 17327963
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline states: pharmacotherapy and psychobiology of personality. A discussion of Soloff's article.
    Rosenberg R
    Acta Psychiatr Scand Suppl; 1994; 379():56-60. PubMed ID: 7912036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
    Findling RL; Mankoski R; Timko K; Lears K; McCartney T; McQuade RD; Eudicone JM; Amatniek J; Marcus RN; Sheehan JJ
    J Clin Psychiatry; 2014 Jan; 75(1):22-30. PubMed ID: 24502859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study.
    Pascual JC; Soler J; Puigdemont D; Pérez-Egea R; Tiana T; Alvarez E; Pérez V
    J Clin Psychiatry; 2008 Apr; 69(4):603-8. PubMed ID: 18251623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapy of the borderline patient.
    Jerome L
    Can J Psychiatry; 1990 Aug; 35(6):572. PubMed ID: 1976431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.